nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftriaxone—GLUL—oviduct—ovarian cancer	0.0422	0.182	CbGeAlD
Ceftriaxone—GLUL—myometrium—ovarian cancer	0.0135	0.0581	CbGeAlD
Ceftriaxone—GLUL—embryo—ovarian cancer	0.013	0.0559	CbGeAlD
Ceftriaxone—GLUL—epithelium—ovarian cancer	0.0106	0.0456	CbGeAlD
Ceftriaxone—GLUL—uterine cervix—ovarian cancer	0.0105	0.0452	CbGeAlD
Ceftriaxone—GLUL—decidua—ovarian cancer	0.01	0.0431	CbGeAlD
Ceftriaxone—GLUL—endometrium—ovarian cancer	0.0095	0.0409	CbGeAlD
Ceftriaxone—GLUL—gonad—ovarian cancer	0.00881	0.0379	CbGeAlD
Ceftriaxone—SLC15A1—epithelium—ovarian cancer	0.00876	0.0377	CbGeAlD
Ceftriaxone—GLUL—uterus—ovarian cancer	0.00876	0.0377	CbGeAlD
Ceftriaxone—SLC22A11—female reproductive system—ovarian cancer	0.0083	0.0357	CbGeAlD
Ceftriaxone—GLUL—female reproductive system—ovarian cancer	0.00787	0.0339	CbGeAlD
Ceftriaxone—SLC15A1—endometrium—ovarian cancer	0.00786	0.0338	CbGeAlD
Ceftriaxone—GLUL—bone marrow—ovarian cancer	0.00743	0.032	CbGeAlD
Ceftriaxone—GLUL—female gonad—ovarian cancer	0.00716	0.0308	CbGeAlD
Ceftriaxone—GLUL—vagina—ovarian cancer	0.00712	0.0306	CbGeAlD
Ceftriaxone—GLUL—testis—ovarian cancer	0.00635	0.0273	CbGeAlD
Ceftriaxone—SLC15A1—vagina—ovarian cancer	0.00588	0.0253	CbGeAlD
Ceftriaxone—SLC15A2—uterine cervix—ovarian cancer	0.00543	0.0234	CbGeAlD
Ceftriaxone—SLC15A2—endometrium—ovarian cancer	0.00491	0.0211	CbGeAlD
Ceftriaxone—GLUL—lymph node—ovarian cancer	0.0046	0.0198	CbGeAlD
Ceftriaxone—SLC15A2—female reproductive system—ovarian cancer	0.00407	0.0175	CbGeAlD
Ceftriaxone—ALB—testis—ovarian cancer	0.00393	0.0169	CbGeAlD
Ceftriaxone—SLC15A2—female gonad—ovarian cancer	0.0037	0.0159	CbGeAlD
Ceftriaxone—SLC15A2—vagina—ovarian cancer	0.00368	0.0158	CbGeAlD
Ceftriaxone—SLC15A2—testis—ovarian cancer	0.00328	0.0141	CbGeAlD
Ceftriaxone—ALB—lymph node—ovarian cancer	0.00285	0.0123	CbGeAlD
Ceftriaxone—SLC15A2—lymph node—ovarian cancer	0.00238	0.0102	CbGeAlD
Ceftriaxone—Aplastic anaemia—Epirubicin—ovarian cancer	0.00154	0.002	CcSEcCtD
Ceftriaxone—Dyspepsia—Melphalan—ovarian cancer	0.00153	0.002	CcSEcCtD
Ceftriaxone—Haematuria—Paclitaxel—ovarian cancer	0.00153	0.00199	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00152	0.00198	CcSEcCtD
Ceftriaxone—Pain—Topotecan—ovarian cancer	0.00152	0.00198	CcSEcCtD
Ceftriaxone—Vaginal inflammation—Doxorubicin—ovarian cancer	0.00152	0.00198	CcSEcCtD
Ceftriaxone—Epistaxis—Paclitaxel—ovarian cancer	0.00151	0.00197	CcSEcCtD
Ceftriaxone—Infection—Vinorelbine—ovarian cancer	0.00151	0.00197	CcSEcCtD
Ceftriaxone—Bronchospasm—Docetaxel—ovarian cancer	0.0015	0.00195	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00149	0.00194	CcSEcCtD
Ceftriaxone—Pain—Melphalan—ovarian cancer	0.00149	0.00194	CcSEcCtD
Ceftriaxone—Hypersensitivity—Chlorambucil—ovarian cancer	0.00147	0.00192	CcSEcCtD
Ceftriaxone—Feeling abnormal—Topotecan—ovarian cancer	0.00146	0.00191	CcSEcCtD
Ceftriaxone—Colitis—Doxorubicin—ovarian cancer	0.00146	0.0019	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Topotecan—ovarian cancer	0.00145	0.00189	CcSEcCtD
Ceftriaxone—Candida infection—Doxorubicin—ovarian cancer	0.00145	0.00189	CcSEcCtD
Ceftriaxone—Haemoglobin—Paclitaxel—ovarian cancer	0.00145	0.00188	CcSEcCtD
Ceftriaxone—Haemorrhage—Paclitaxel—ovarian cancer	0.00144	0.00187	CcSEcCtD
Ceftriaxone—Hypertonia—Epirubicin—ovarian cancer	0.00144	0.00187	CcSEcCtD
Ceftriaxone—Vaginal infection—Doxorubicin—ovarian cancer	0.00143	0.00186	CcSEcCtD
Ceftriaxone—Neutropenia—Docetaxel—ovarian cancer	0.00143	0.00186	CcSEcCtD
Ceftriaxone—Aplastic anaemia—Doxorubicin—ovarian cancer	0.00142	0.00185	CcSEcCtD
Ceftriaxone—Pruritus—Chlorambucil—ovarian cancer	0.00141	0.00184	CcSEcCtD
Ceftriaxone—Urticaria—Topotecan—ovarian cancer	0.00141	0.00184	CcSEcCtD
Ceftriaxone—Body temperature increased—Topotecan—ovarian cancer	0.0014	0.00183	CcSEcCtD
Ceftriaxone—Abdominal pain—Topotecan—ovarian cancer	0.0014	0.00183	CcSEcCtD
Ceftriaxone—Urticaria—Melphalan—ovarian cancer	0.00138	0.0018	CcSEcCtD
Ceftriaxone—Phlebitis—Epirubicin—ovarian cancer	0.00138	0.0018	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Epirubicin—ovarian cancer	0.00137	0.00179	CcSEcCtD
Ceftriaxone—Diarrhoea—Chlorambucil—ovarian cancer	0.00137	0.00178	CcSEcCtD
Ceftriaxone—Paraesthesia—Vinorelbine—ovarian cancer	0.00136	0.00178	CcSEcCtD
Ceftriaxone—Hepatic function abnormal—Epirubicin—ovarian cancer	0.00136	0.00177	CcSEcCtD
Ceftriaxone—Erythema multiforme—Paclitaxel—ovarian cancer	0.00136	0.00177	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.00135	0.00176	CcSEcCtD
Ceftriaxone—Renal failure—Docetaxel—ovarian cancer	0.00134	0.00174	CcSEcCtD
Ceftriaxone—Flushing—Paclitaxel—ovarian cancer	0.00134	0.00174	CcSEcCtD
Ceftriaxone—Hypertonia—Doxorubicin—ovarian cancer	0.00133	0.00173	CcSEcCtD
Ceftriaxone—Stomatitis—Docetaxel—ovarian cancer	0.00132	0.00173	CcSEcCtD
Ceftriaxone—Jaundice—Docetaxel—ovarian cancer	0.00132	0.00173	CcSEcCtD
Ceftriaxone—Hypersensitivity—Topotecan—ovarian cancer	0.00131	0.00171	CcSEcCtD
Ceftriaxone—Pain—Vinorelbine—ovarian cancer	0.0013	0.00169	CcSEcCtD
Ceftriaxone—Chills—Paclitaxel—ovarian cancer	0.00129	0.00168	CcSEcCtD
Ceftriaxone—Hypersensitivity—Melphalan—ovarian cancer	0.00128	0.00167	CcSEcCtD
Ceftriaxone—Epistaxis—Docetaxel—ovarian cancer	0.00128	0.00167	CcSEcCtD
Ceftriaxone—Phlebitis—Doxorubicin—ovarian cancer	0.00128	0.00166	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Doxorubicin—ovarian cancer	0.00127	0.00166	CcSEcCtD
Ceftriaxone—Vomiting—Chlorambucil—ovarian cancer	0.00127	0.00165	CcSEcCtD
Ceftriaxone—Agranulocytosis—Docetaxel—ovarian cancer	0.00127	0.00165	CcSEcCtD
Ceftriaxone—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.00126	0.00164	CcSEcCtD
Ceftriaxone—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.00126	0.00164	CcSEcCtD
Ceftriaxone—Pruritus—Topotecan—ovarian cancer	0.00126	0.00164	CcSEcCtD
Ceftriaxone—Feeling abnormal—Vinorelbine—ovarian cancer	0.00125	0.00163	CcSEcCtD
Ceftriaxone—Renal impairment—Epirubicin—ovarian cancer	0.00125	0.00163	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00124	0.00162	CcSEcCtD
Ceftriaxone—Flatulence—Paclitaxel—ovarian cancer	0.00123	0.00161	CcSEcCtD
Ceftriaxone—Pruritus—Melphalan—ovarian cancer	0.00123	0.0016	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.00123	0.0016	CcSEcCtD
Ceftriaxone—Dysgeusia—Paclitaxel—ovarian cancer	0.00123	0.0016	CcSEcCtD
Ceftriaxone—Haemoglobin—Docetaxel—ovarian cancer	0.00123	0.0016	CcSEcCtD
Ceftriaxone—Haemorrhage—Docetaxel—ovarian cancer	0.00122	0.00159	CcSEcCtD
Ceftriaxone—Diarrhoea—Topotecan—ovarian cancer	0.00122	0.00158	CcSEcCtD
Ceftriaxone—Urticaria—Vinorelbine—ovarian cancer	0.00121	0.00157	CcSEcCtD
Ceftriaxone—Abdominal pain—Vinorelbine—ovarian cancer	0.0012	0.00157	CcSEcCtD
Ceftriaxone—Body temperature increased—Vinorelbine—ovarian cancer	0.0012	0.00157	CcSEcCtD
Ceftriaxone—Diarrhoea—Melphalan—ovarian cancer	0.00119	0.00155	CcSEcCtD
Ceftriaxone—Nausea—Chlorambucil—ovarian cancer	0.00119	0.00154	CcSEcCtD
Ceftriaxone—Dizziness—Topotecan—ovarian cancer	0.00118	0.00153	CcSEcCtD
Ceftriaxone—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.00117	0.00152	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00116	0.00151	CcSEcCtD
Ceftriaxone—Anaemia—Paclitaxel—ovarian cancer	0.00116	0.00151	CcSEcCtD
Ceftriaxone—Renal impairment—Doxorubicin—ovarian cancer	0.00116	0.00151	CcSEcCtD
Ceftriaxone—Erythema multiforme—Docetaxel—ovarian cancer	0.00115	0.0015	CcSEcCtD
Ceftriaxone—Agitation—Paclitaxel—ovarian cancer	0.00115	0.0015	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.00114	0.00148	CcSEcCtD
Ceftriaxone—Flushing—Docetaxel—ovarian cancer	0.00113	0.00147	CcSEcCtD
Ceftriaxone—Vomiting—Topotecan—ovarian cancer	0.00113	0.00147	CcSEcCtD
Ceftriaxone—Malaise—Paclitaxel—ovarian cancer	0.00113	0.00147	CcSEcCtD
Ceftriaxone—Leukopenia—Paclitaxel—ovarian cancer	0.00112	0.00146	CcSEcCtD
Ceftriaxone—Rash—Topotecan—ovarian cancer	0.00112	0.00146	CcSEcCtD
Ceftriaxone—Hypersensitivity—Vinorelbine—ovarian cancer	0.00112	0.00146	CcSEcCtD
Ceftriaxone—Dermatitis—Topotecan—ovarian cancer	0.00112	0.00146	CcSEcCtD
Ceftriaxone—Ataxia—Epirubicin—ovarian cancer	0.00112	0.00146	CcSEcCtD
Ceftriaxone—Blood creatinine increased—Epirubicin—ovarian cancer	0.00111	0.00145	CcSEcCtD
Ceftriaxone—Headache—Topotecan—ovarian cancer	0.00111	0.00145	CcSEcCtD
Ceftriaxone—Palpitations—Paclitaxel—ovarian cancer	0.00111	0.00144	CcSEcCtD
Ceftriaxone—Vomiting—Melphalan—ovarian cancer	0.00111	0.00144	CcSEcCtD
Ceftriaxone—Rash—Melphalan—ovarian cancer	0.0011	0.00143	CcSEcCtD
Ceftriaxone—Dermatitis—Melphalan—ovarian cancer	0.0011	0.00143	CcSEcCtD
Ceftriaxone—Chills—Docetaxel—ovarian cancer	0.00109	0.00143	CcSEcCtD
Ceftriaxone—Abdominal pain upper—Epirubicin—ovarian cancer	0.00109	0.00142	CcSEcCtD
Ceftriaxone—Convulsion—Paclitaxel—ovarian cancer	0.00109	0.00141	CcSEcCtD
Ceftriaxone—Pruritus—Vinorelbine—ovarian cancer	0.00108	0.0014	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.00107	0.0014	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.00107	0.0014	CcSEcCtD
Ceftriaxone—Nausea—Topotecan—ovarian cancer	0.00106	0.00138	CcSEcCtD
Ceftriaxone—Discomfort—Paclitaxel—ovarian cancer	0.00105	0.00137	CcSEcCtD
Ceftriaxone—Diarrhoea—Vinorelbine—ovarian cancer	0.00104	0.00135	CcSEcCtD
Ceftriaxone—Dysgeusia—Docetaxel—ovarian cancer	0.00104	0.00135	CcSEcCtD
Ceftriaxone—Ataxia—Doxorubicin—ovarian cancer	0.00103	0.00135	CcSEcCtD
Ceftriaxone—Nausea—Melphalan—ovarian cancer	0.00103	0.00135	CcSEcCtD
Ceftriaxone—Blood creatinine increased—Doxorubicin—ovarian cancer	0.00103	0.00134	CcSEcCtD
Ceftriaxone—Oedema—Paclitaxel—ovarian cancer	0.00102	0.00133	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00102	0.00133	CcSEcCtD
Ceftriaxone—Eosinophilia—Epirubicin—ovarian cancer	0.00102	0.00133	CcSEcCtD
Ceftriaxone—Infection—Paclitaxel—ovarian cancer	0.00102	0.00132	CcSEcCtD
Ceftriaxone—Pancreatitis—Epirubicin—ovarian cancer	0.00101	0.00131	CcSEcCtD
Ceftriaxone—Dizziness—Vinorelbine—ovarian cancer	0.00101	0.00131	CcSEcCtD
Ceftriaxone—Abdominal pain upper—Doxorubicin—ovarian cancer	0.00101	0.00131	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Paclitaxel—ovarian cancer	0.001	0.0013	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000991	0.00129	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000991	0.00129	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000988	0.00129	CcSEcCtD
Ceftriaxone—Anaemia—Docetaxel—ovarian cancer	0.000981	0.00128	CcSEcCtD
Ceftriaxone—Vomiting—Vinorelbine—ovarian cancer	0.000967	0.00126	CcSEcCtD
Ceftriaxone—Neutropenia—Epirubicin—ovarian cancer	0.000961	0.00125	CcSEcCtD
Ceftriaxone—Rash—Vinorelbine—ovarian cancer	0.000958	0.00125	CcSEcCtD
Ceftriaxone—Dermatitis—Vinorelbine—ovarian cancer	0.000958	0.00125	CcSEcCtD
Ceftriaxone—Headache—Vinorelbine—ovarian cancer	0.000952	0.00124	CcSEcCtD
Ceftriaxone—Leukopenia—Docetaxel—ovarian cancer	0.000951	0.00124	CcSEcCtD
Ceftriaxone—Eosinophilia—Doxorubicin—ovarian cancer	0.000942	0.00123	CcSEcCtD
Ceftriaxone—Palpitations—Docetaxel—ovarian cancer	0.000938	0.00122	CcSEcCtD
Ceftriaxone—Pancreatitis—Doxorubicin—ovarian cancer	0.000933	0.00121	CcSEcCtD
Ceftriaxone—Convulsion—Docetaxel—ovarian cancer	0.00092	0.0012	CcSEcCtD
Ceftriaxone—Paraesthesia—Paclitaxel—ovarian cancer	0.000918	0.0012	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000909	0.00118	CcSEcCtD
Ceftriaxone—Nausea—Vinorelbine—ovarian cancer	0.000903	0.00118	CcSEcCtD
Ceftriaxone—Renal failure—Epirubicin—ovarian cancer	0.000901	0.00117	CcSEcCtD
Ceftriaxone—Dyspepsia—Paclitaxel—ovarian cancer	0.0009	0.00117	CcSEcCtD
Ceftriaxone—Stomatitis—Epirubicin—ovarian cancer	0.000893	0.00116	CcSEcCtD
Ceftriaxone—Jaundice—Epirubicin—ovarian cancer	0.000893	0.00116	CcSEcCtD
Ceftriaxone—Neutropenia—Doxorubicin—ovarian cancer	0.000889	0.00116	CcSEcCtD
Ceftriaxone—Pain—Paclitaxel—ovarian cancer	0.000874	0.00114	CcSEcCtD
Ceftriaxone—Haematuria—Epirubicin—ovarian cancer	0.000874	0.00114	CcSEcCtD
Ceftriaxone—Oedema—Docetaxel—ovarian cancer	0.000867	0.00113	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Docetaxel—ovarian cancer	0.000867	0.00113	CcSEcCtD
Ceftriaxone—Epistaxis—Epirubicin—ovarian cancer	0.000864	0.00113	CcSEcCtD
Ceftriaxone—Infection—Docetaxel—ovarian cancer	0.000861	0.00112	CcSEcCtD
Ceftriaxone—Agranulocytosis—Epirubicin—ovarian cancer	0.000855	0.00111	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Docetaxel—ovarian cancer	0.000849	0.00111	CcSEcCtD
Ceftriaxone—Feeling abnormal—Paclitaxel—ovarian cancer	0.000843	0.0011	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000841	0.0011	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000836	0.00109	CcSEcCtD
Ceftriaxone—Renal failure—Doxorubicin—ovarian cancer	0.000834	0.00109	CcSEcCtD
Ceftriaxone—Haemoglobin—Epirubicin—ovarian cancer	0.000827	0.00108	CcSEcCtD
Ceftriaxone—Jaundice—Doxorubicin—ovarian cancer	0.000827	0.00108	CcSEcCtD
Ceftriaxone—Stomatitis—Doxorubicin—ovarian cancer	0.000827	0.00108	CcSEcCtD
Ceftriaxone—Haemorrhage—Epirubicin—ovarian cancer	0.000823	0.00107	CcSEcCtD
Ceftriaxone—Urticaria—Paclitaxel—ovarian cancer	0.000812	0.00106	CcSEcCtD
Ceftriaxone—Haematuria—Doxorubicin—ovarian cancer	0.000809	0.00105	CcSEcCtD
Ceftriaxone—Body temperature increased—Paclitaxel—ovarian cancer	0.000808	0.00105	CcSEcCtD
Ceftriaxone—Abdominal pain—Paclitaxel—ovarian cancer	0.000808	0.00105	CcSEcCtD
Ceftriaxone—Epistaxis—Doxorubicin—ovarian cancer	0.0008	0.00104	CcSEcCtD
Ceftriaxone—Agranulocytosis—Doxorubicin—ovarian cancer	0.000791	0.00103	CcSEcCtD
Ceftriaxone—Paraesthesia—Docetaxel—ovarian cancer	0.000778	0.00101	CcSEcCtD
Ceftriaxone—Erythema multiforme—Epirubicin—ovarian cancer	0.000778	0.00101	CcSEcCtD
Ceftriaxone—Haemoglobin—Doxorubicin—ovarian cancer	0.000765	0.000997	CcSEcCtD
Ceftriaxone—Flushing—Epirubicin—ovarian cancer	0.000764	0.000995	CcSEcCtD
Ceftriaxone—Dyspepsia—Docetaxel—ovarian cancer	0.000763	0.000994	CcSEcCtD
Ceftriaxone—Haemorrhage—Doxorubicin—ovarian cancer	0.000761	0.000992	CcSEcCtD
Ceftriaxone—Hypersensitivity—Paclitaxel—ovarian cancer	0.000753	0.000981	CcSEcCtD
Ceftriaxone—Pain—Docetaxel—ovarian cancer	0.000741	0.000965	CcSEcCtD
Ceftriaxone—Chills—Epirubicin—ovarian cancer	0.000738	0.000962	CcSEcCtD
Ceftriaxone—Pruritus—Paclitaxel—ovarian cancer	0.000723	0.000942	CcSEcCtD
Ceftriaxone—Erythema multiforme—Doxorubicin—ovarian cancer	0.00072	0.000938	CcSEcCtD
Ceftriaxone—Feeling abnormal—Docetaxel—ovarian cancer	0.000714	0.00093	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000709	0.000923	CcSEcCtD
Ceftriaxone—Flushing—Doxorubicin—ovarian cancer	0.000707	0.00092	CcSEcCtD
Ceftriaxone—Flatulence—Epirubicin—ovarian cancer	0.000706	0.000919	CcSEcCtD
Ceftriaxone—Dysgeusia—Epirubicin—ovarian cancer	0.000701	0.000914	CcSEcCtD
Ceftriaxone—Diarrhoea—Paclitaxel—ovarian cancer	0.0007	0.000911	CcSEcCtD
Ceftriaxone—Abdominal pain—Docetaxel—ovarian cancer	0.000685	0.000893	CcSEcCtD
Ceftriaxone—Body temperature increased—Docetaxel—ovarian cancer	0.000685	0.000893	CcSEcCtD
Ceftriaxone—Chills—Doxorubicin—ovarian cancer	0.000683	0.00089	CcSEcCtD
Ceftriaxone—Dizziness—Paclitaxel—ovarian cancer	0.000676	0.000881	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Epirubicin—ovarian cancer	0.000665	0.000866	CcSEcCtD
Ceftriaxone—Anaemia—Epirubicin—ovarian cancer	0.000662	0.000862	CcSEcCtD
Ceftriaxone—Agitation—Epirubicin—ovarian cancer	0.000658	0.000857	CcSEcCtD
Ceftriaxone—Flatulence—Doxorubicin—ovarian cancer	0.000653	0.000851	CcSEcCtD
Ceftriaxone—Vomiting—Paclitaxel—ovarian cancer	0.00065	0.000847	CcSEcCtD
Ceftriaxone—Dysgeusia—Doxorubicin—ovarian cancer	0.000649	0.000845	CcSEcCtD
Ceftriaxone—Malaise—Epirubicin—ovarian cancer	0.000646	0.000841	CcSEcCtD
Ceftriaxone—Rash—Paclitaxel—ovarian cancer	0.000645	0.00084	CcSEcCtD
Ceftriaxone—Dermatitis—Paclitaxel—ovarian cancer	0.000644	0.000839	CcSEcCtD
Ceftriaxone—Leukopenia—Epirubicin—ovarian cancer	0.000641	0.000835	CcSEcCtD
Ceftriaxone—Headache—Paclitaxel—ovarian cancer	0.000641	0.000834	CcSEcCtD
Ceftriaxone—Hypersensitivity—Docetaxel—ovarian cancer	0.000639	0.000832	CcSEcCtD
Ceftriaxone—Palpitations—Epirubicin—ovarian cancer	0.000633	0.000825	CcSEcCtD
Ceftriaxone—Convulsion—Epirubicin—ovarian cancer	0.000621	0.000808	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000615	0.000801	CcSEcCtD
Ceftriaxone—Pruritus—Docetaxel—ovarian cancer	0.000613	0.000799	CcSEcCtD
Ceftriaxone—Anaemia—Doxorubicin—ovarian cancer	0.000613	0.000798	CcSEcCtD
Ceftriaxone—Agitation—Doxorubicin—ovarian cancer	0.000609	0.000793	CcSEcCtD
Ceftriaxone—Nausea—Paclitaxel—ovarian cancer	0.000607	0.000791	CcSEcCtD
Ceftriaxone—Discomfort—Epirubicin—ovarian cancer	0.000602	0.000785	CcSEcCtD
Ceftriaxone—Malaise—Doxorubicin—ovarian cancer	0.000598	0.000779	CcSEcCtD
Ceftriaxone—Leukopenia—Doxorubicin—ovarian cancer	0.000593	0.000773	CcSEcCtD
Ceftriaxone—Diarrhoea—Docetaxel—ovarian cancer	0.000593	0.000773	CcSEcCtD
Ceftriaxone—Palpitations—Doxorubicin—ovarian cancer	0.000586	0.000763	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Epirubicin—ovarian cancer	0.000585	0.000762	CcSEcCtD
Ceftriaxone—Oedema—Epirubicin—ovarian cancer	0.000585	0.000762	CcSEcCtD
Ceftriaxone—Infection—Epirubicin—ovarian cancer	0.000581	0.000757	CcSEcCtD
Ceftriaxone—Convulsion—Doxorubicin—ovarian cancer	0.000574	0.000748	CcSEcCtD
Ceftriaxone—Dizziness—Docetaxel—ovarian cancer	0.000573	0.000747	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Epirubicin—ovarian cancer	0.000572	0.000746	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Epirubicin—ovarian cancer	0.000565	0.000736	CcSEcCtD
Ceftriaxone—Discomfort—Doxorubicin—ovarian cancer	0.000557	0.000726	CcSEcCtD
Ceftriaxone—Vomiting—Docetaxel—ovarian cancer	0.000551	0.000718	CcSEcCtD
Ceftriaxone—Rash—Docetaxel—ovarian cancer	0.000546	0.000712	CcSEcCtD
Ceftriaxone—Dermatitis—Docetaxel—ovarian cancer	0.000546	0.000711	CcSEcCtD
Ceftriaxone—Headache—Docetaxel—ovarian cancer	0.000543	0.000707	CcSEcCtD
Ceftriaxone—Oedema—Doxorubicin—ovarian cancer	0.000541	0.000705	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000541	0.000705	CcSEcCtD
Ceftriaxone—Infection—Doxorubicin—ovarian cancer	0.000537	0.0007	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Doxorubicin—ovarian cancer	0.00053	0.00069	CcSEcCtD
Ceftriaxone—Paraesthesia—Epirubicin—ovarian cancer	0.000525	0.000684	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000523	0.000681	CcSEcCtD
Ceftriaxone—Nausea—Docetaxel—ovarian cancer	0.000515	0.000671	CcSEcCtD
Ceftriaxone—Dyspepsia—Epirubicin—ovarian cancer	0.000515	0.00067	CcSEcCtD
Ceftriaxone—Pain—Epirubicin—ovarian cancer	0.0005	0.000651	CcSEcCtD
Ceftriaxone—Paraesthesia—Doxorubicin—ovarian cancer	0.000486	0.000633	CcSEcCtD
Ceftriaxone—Feeling abnormal—Epirubicin—ovarian cancer	0.000482	0.000628	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000478	0.000623	CcSEcCtD
Ceftriaxone—Dyspepsia—Doxorubicin—ovarian cancer	0.000476	0.00062	CcSEcCtD
Ceftriaxone—Urticaria—Epirubicin—ovarian cancer	0.000464	0.000605	CcSEcCtD
Ceftriaxone—Pain—Doxorubicin—ovarian cancer	0.000463	0.000603	CcSEcCtD
Ceftriaxone—Abdominal pain—Epirubicin—ovarian cancer	0.000462	0.000602	CcSEcCtD
Ceftriaxone—Body temperature increased—Epirubicin—ovarian cancer	0.000462	0.000602	CcSEcCtD
Ceftriaxone—Feeling abnormal—Doxorubicin—ovarian cancer	0.000446	0.000581	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000442	0.000576	CcSEcCtD
Ceftriaxone—Hypersensitivity—Epirubicin—ovarian cancer	0.000431	0.000561	CcSEcCtD
Ceftriaxone—Urticaria—Doxorubicin—ovarian cancer	0.00043	0.00056	CcSEcCtD
Ceftriaxone—Abdominal pain—Doxorubicin—ovarian cancer	0.000428	0.000557	CcSEcCtD
Ceftriaxone—Body temperature increased—Doxorubicin—ovarian cancer	0.000428	0.000557	CcSEcCtD
Ceftriaxone—Pruritus—Epirubicin—ovarian cancer	0.000414	0.000539	CcSEcCtD
Ceftriaxone—Diarrhoea—Epirubicin—ovarian cancer	0.0004	0.000521	CcSEcCtD
Ceftriaxone—Hypersensitivity—Doxorubicin—ovarian cancer	0.000398	0.000519	CcSEcCtD
Ceftriaxone—Dizziness—Epirubicin—ovarian cancer	0.000387	0.000504	CcSEcCtD
Ceftriaxone—Pruritus—Doxorubicin—ovarian cancer	0.000383	0.000499	CcSEcCtD
Ceftriaxone—Vomiting—Epirubicin—ovarian cancer	0.000372	0.000484	CcSEcCtD
Ceftriaxone—Diarrhoea—Doxorubicin—ovarian cancer	0.00037	0.000482	CcSEcCtD
Ceftriaxone—Rash—Epirubicin—ovarian cancer	0.000369	0.00048	CcSEcCtD
Ceftriaxone—Dermatitis—Epirubicin—ovarian cancer	0.000368	0.00048	CcSEcCtD
Ceftriaxone—Headache—Epirubicin—ovarian cancer	0.000366	0.000477	CcSEcCtD
Ceftriaxone—Dizziness—Doxorubicin—ovarian cancer	0.000358	0.000466	CcSEcCtD
Ceftriaxone—Nausea—Epirubicin—ovarian cancer	0.000347	0.000452	CcSEcCtD
Ceftriaxone—Vomiting—Doxorubicin—ovarian cancer	0.000344	0.000448	CcSEcCtD
Ceftriaxone—Rash—Doxorubicin—ovarian cancer	0.000341	0.000444	CcSEcCtD
Ceftriaxone—Dermatitis—Doxorubicin—ovarian cancer	0.000341	0.000444	CcSEcCtD
Ceftriaxone—Headache—Doxorubicin—ovarian cancer	0.000339	0.000441	CcSEcCtD
Ceftriaxone—Nausea—Doxorubicin—ovarian cancer	0.000321	0.000419	CcSEcCtD
